EyeGate Pharmaceuticals I... (EYEG)

NASDAQ: EYEG · Real-Time Price · USD

35.26

0.00 (0.00%)

At close: Apr 28, 2025, 3:07 PM

35.31

0.16%

After-hours: Apr 29, 2025, 04:00 PM EDT

EyeGate Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	3.59M	-8.09M	-7.1M	-10.81M	-13.22M	-13.34M
Depreciation & Amortization	19.2K	33.4K	213.93K	38.48K	19.29K	5.18K
Stock-Based Compensation	656.59K	723.86K	852.23K	875.29K	870.31K	511K
Other Working Capital	n/a	37.82K	-1.85M	11.63M	-2.51M	-9.89M
Other Non-Cash Items	4.58M	2.88M	-514.25K	-12.02M	10.42M	13.6M
Deferred Income Tax	-288.75K	12.05K	95.4K	86.05K	-1.34M	n/a
Change in Working Capital	n/a	-2.87M	-1.7M	10.99M	-3.22M	-9.18M
Operating Cash Flow	8.56M	-7.32M	-8.15M	-10.84M	-6.47M	-8.41M
Capital Expenditures	-6.26K	-133.79K	n/a	-270K	-37K	-11K
Cash Acquisitions	n/a	-110.64K	n/a	n/a	n/a	185.75K
Purchase of Investments	-35.63M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	12.98M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	-25K
Investing Cash Flow	-22.66M	-244.44K	n/a	-270K	-37K	149.75K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	15.5M	5M	3.92M	11.3M	10.67M	3.5M
Financial Cash Flow	15.5M	5M	3.92M	11.3M	10.67M	3.5M
Net Cash Flow	1.34M	-2.59M	-4.23M	198.21K	4.17M	-4.76M
Free Cash Flow	8.55M	-7.45M	-8.15M	-11.11M	-6.51M	-8.42M